首页> 外文期刊>Acta Radiologica Short Reports >MRI-guided laser ablation of neuroendocrine tumor hepatic metastases
【24h】

MRI-guided laser ablation of neuroendocrine tumor hepatic metastases

机译:MRI引导的神经内分泌肿瘤肝转移的激光消融

获取原文
       

摘要

Neuroendocrine tumors (NET) represent a therapeutically challenging and heterogeneous group of malignancies occurring throughout the body, but mainly in the gastrointestinal system. To describe magnetic resonance imaging (MRI)-guided laser ablation of NET liver metastases and assess its role within the current treatment options and methods. Two patients with NET tumor hepatic metastases were treated with MRI-guided interstitial laser ablation (LITT). Three tumors were treated. Clinical follow-up time was 10 years. Both patients were successfully treated. There were no local recurrences at the ablation site during the follow-up. Both patients had survived at 10-year follow-up. One patient is disease-free. MRI-guided laser ablation can be used to treat NET tumor liver metastases but combination therapy and a rigorous follow-up schedule are recommended.
机译:神经内分泌肿瘤(NET)代表了在整个身体中但主要在胃肠系统中发生的具有治疗挑战性和异质性的一组恶性肿瘤。描述磁共振成像(MRI)引导的NET肝转移的激光消融,并评估其在当前治疗方案和方法中的作用。两名患有NET肿瘤肝转移的患者接受了MRI引导的间隙激光消融(LITT)治疗。治疗了三种肿瘤。临床随访时间为10年。两名患者均已成功治疗。随访期间在消融部位无局部复发。两名患者均在10年的随访中存活。一名患者无病。 MRI引导的激光消融可用于治疗NET肿瘤肝脏转移,但建议联合治疗和严格的随访计划。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号